Article info

Download PDFPDF
Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients

Authors

  • Fernanda Genre Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IFIMAV, Santander, Spain PubMed articlesGoogle scholar articles
  • Raquel López-Mejías Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IFIMAV, Santander, Spain PubMed articlesGoogle scholar articles
  • José A Miranda-Filloy Rheumatology Division, Hospital Xeral-Calde, Lugo, Spain PubMed articlesGoogle scholar articles
  • Begoña Ubilla Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IFIMAV, Santander, Spain PubMed articlesGoogle scholar articles
  • Beatriz Carnero-López Oncology Division, Hospital Del Bierzo, Ponferrada, León, Spain PubMed articlesGoogle scholar articles
  • Inés Gómez-Acebo Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, IFIMAV, and CIBER Epidemiología y Salud Pública (CIBERESP), Santander, Spain PubMed articlesGoogle scholar articles
  • Ricardo Blanco Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IFIMAV, Santander, Spain PubMed articlesGoogle scholar articles
  • Rodrigo Ochoa Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IFIMAV, Santander, Spain PubMed articlesGoogle scholar articles
  • Javier Rueda-Gotor Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IFIMAV, Santander, Spain PubMed articlesGoogle scholar articles
  • Trinitario Pina Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IFIMAV, Santander, Spain PubMed articlesGoogle scholar articles
  • Carlos González-Juanatey Cardiology Division, Hospital Xeral-Calde, Lugo, Spain PubMed articlesGoogle scholar articles
  • Javier Llorca Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, IFIMAV, and CIBER Epidemiología y Salud Pública (CIBERESP), Santander, Spain PubMed articlesGoogle scholar articles
  • Miguel A González-Gay Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IFIMAV, Santander, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Miguel A González-Gay, Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IFIMAV, Avenida de Valdecilla, s/n, Santander 39008, Spain; miguelaggay{at}hotmail.com
View Full Text

Citation

Genre F, López-Mejías R, Miranda-Filloy JA, et al
Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients

Publication history

  • Received August 19, 2013
  • Revised September 20, 2013
  • Accepted November 24, 2013
  • First published December 9, 2013.
Online issue publication 
April 04, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.